Ben Holmes

A Bonny Week for IPOs

 

The syndicate market over the past five days has been absolutely spectacular. Of the six deals that priced, five of them had great first-day performances, while one of them was a real stinker.

The stinker was DJ Orthopedics(DJO), which broke its $17 issue price almost immediately to end the day down more than 10%. I want to own up to this one and say that I missed the call.

The truth is that I heard a rumor a couple of hours before the stock priced. The story was that some large orders had been canceled and that the deal was in trouble. I chalked this up to rumormongering and held my positive opinion. My rationale was that someone was trying to shake out some weak indications of interest (IOIs) and free up some deal stock. Man, was I wrong.

That being said, the remainder of this week's deals traded as well as I had hoped. Readers have been emailing to say that they received deal stock in Weight Watchers(WTW), AMN Healthcare(AHS) and even Advisory Board(ABCO), and that they were stoked with the gains. Fisher & Paykel's(FPHC) and Cross Country's(CCRN) IPOs also did well.

Some brave souls (you are my heroes!) even wrote that they had blown their stock and taken the profits. To these people I say "right on!" Don't you listen to anyone who says you'll be shut out for selling. You're not in this to make the brokers like you, you're in this to make money!

If you don't get any more stock from that broker, you can whine about it over coffee (paid for with your WTW gains) while you fill out the account opening forms from another underwriting firm.

Be hard. Be focused. Be clear why you're in the market in the first place.

I'm taking a much-needed vacation next week. See you when I get back.

>To order reprints of this article, click here: Reprints

Ben Holmes is the founder of ipoPros.com, a Boulder, Colo.-based research boutique (now a wholly-owned subsidiary of TheStreet.com) specializing in the analysis of equity syndicate offerings. This column is not meant as investment advice; it is instead meant to provide insight into the methods of new and secondary offerings. Neither Holmes nor his firm has entered indications of interest in any of the companies discussed in this column. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Holmes appreciates your feedback and invites you to send it to Ben Holmes.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet